Article
Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia.
BMC infectious diseases - 25 Jul 2020
Ershova Julia V, Volchenkov Grigory V, Somova Tatiana R, Kuznetsova Tatiana A, Kaunetis Natalia V, Kaminski Dorothy, Demikhova Olga V, Chernousova Larisa N, Vasilyeva Irina A, Kerr Eleanor M, Cegielski J Peter, Kurbatova Ekaterina V
Abstract excerpt
BACKGROUND: The main advantage of GeneXpert MTB/RIF® (Xpert) molecular diagnostic technology is the rapid detection of M.tuberculosis DNA and mutations associated with rifampicin (RIF) resistance for timely initiation of appropriate treatment and, consequently, preventing further transmission of the disease. We assessed time to treatment initiation and treatment outcomes of RIF-resistant and RIF-susceptible TB...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.